Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
1.370
-0.110 (-7.43%)
Oct 16, 2026, 9:58 AM EDT - Market open
Anavex Life Sciences Market Cap
Anavex Life Sciences has a market cap or net worth of $126.99 million as of October 16, 2026. It is the 23,173rd most valuable company in the world and the 3,873rd biggest in the United States. Its market cap has decreased by 83.63% in one year.
Market Cap
126.99M
Enterprise Value
8.67M
1-Year Change
-83.63%
Global Rank
Country Rank
#3,873 United States
Category
ChartMarket Cap Chart
Since October 28, 2015, Anavex Life Sciences's market cap has decreased from $284.60M to $126.99M, a decrease of -55.38%. That is a compound annual growth rate of -7.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 126.99M | -60.08% |
| Dec 31, 2025 | 318.10M | -65.08% |
| Dec 31, 2024 | 910.90M | 19.20% |
| Dec 29, 2023 | 764.20M | 5.86% |
| Dec 30, 2022 | 721.90M | -45.24% |
| Dec 31, 2021 | 1.32B | 264.55% |
| Dec 31, 2020 | 361.60M | 148.69% |
| Dec 31, 2019 | 145.40M | 100.00% |
| Dec 31, 2018 | 72.70M | -48.95% |
| Dec 29, 2017 | 142.40M | -9.24% |
| Dec 30, 2016 | 156.90M | -18.58% |
| Dec 31, 2015 | 192.70M | -32.29% |
| Oct 28, 2015 | 284.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Satellos Bioscience | 146.30M |
| Molecular Partners AG | 145.45M |
| Protara Therapeutics | 141.83M |
| ALX Oncology Holdings | 138.28M |
| Nkarta | 138.24M |
| Korro Bio | 137.10M |
| AN2 Therapeutics | 135.85M |
| Innate Pharma | 135.84M |